Design, synthesis and biological evaluation of CDC20 inhibitors for treatment of triple-negative breast cancer
作者:Shi-Fang Zhao、Jia-Fu Leng、Shan-Shan Xie、Li-Qiao Zhu、Meng-Yu Zhang、Ling-Yi Kong、Yong Yin
DOI:10.1016/j.ejmech.2024.116204
日期:2024.3
different types of human cancers and it disturbs the process of cell division and impedes tumor proliferation. In this work, a novel of Apcin derivatives targeting CDC20 were designed and synthesized to evaluate for their biological activities. The inhibitory effect on the proliferation of four human tumor cell lines (MCF-7, MDA-MB-231, MDA-MB-468 and A549) was observed. Among them, compound exhibited
CDC20参与促进不同类型人类癌症的肿瘤生长,并扰乱细胞分裂过程并阻碍肿瘤增殖。在这项工作中,设计并合成了一种针对 CDC20 的新型 Apcin 衍生物,以评估其生物活性。观察了对四种人肿瘤细胞系(MCF-7、MDA-MB-231、MDA-MB-468和A549)增殖的抑制作用。其中,化合物对MDA-MB-231细胞增殖的抑制作用最强,IC值为1.43 μM,明显优于Apcin。进一步的生物学研究表明,该化合物可抑制癌细胞迁移和集落形成。此外,与Apcin相比,该化合物特异性靶向CDC20并表现出对CDC20更高的结合亲和力,从而诱导癌细胞的细胞周期停滞在G2/M期。此外,已观察到化合物诱导癌细胞自噬。在4T1异种移植模型中,化合物表现出潜在的抗肿瘤活性,且没有明显的毒性。这些发现表明可被视为 CDC20 抑制剂,值得进一步研究。